Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe Haemophilia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07788469
What this trial is testing

Elranatamab for Inhibitor Eradication in Patients With Hemophilia A

Who this might be right for
Hemophilia A With Inhibitors
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableStudy completedNCT02284789
What this trial is testing

Colorado Adult Joint Assessment Scale (CAJAS) Validation

Who this might be right for
Hemophilia A
Bayer 30
Large-scale testing (Phase 3)Study completedNCT03938792
What this trial is testing

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 188
Not applicableWithdrawnNCT02718677
What this trial is testing

Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis

Who this might be right for
Hemophilia A
Pfizer
Post-approval studies (Phase 4)Study completedNCT05728528
What this trial is testing

Impact of Moderate Intensity Physical Activities on PK-guided EHL FVIII Concentrates Prophylaxis Severe HA Patients

Who this might be right for
Hemophilia
Chulalongkorn University 13
Testing effectiveness (Phase 2)Ended earlyNCT02618915
What this trial is testing

Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Ultragenyx Pharmaceutical Inc 6
Testing effectiveness (Phase 2)Looking for participantsNCT06379789
What this trial is testing

Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Who this might be right for
Hemophilia B
Regeneron Pharmaceuticals 130
Large-scale testing (Phase 3)WithdrawnNCT06297486
What this trial is testing

Study of a Gene Therapy Treatment for Hemophilia A

Who this might be right for
Hemophilia A
Spark Therapeutics, Inc.
Not applicableEnded earlyNCT06530030
What this trial is testing

Goal Attainment and Physical Activity in People With Hemophilia A

Who this might be right for
Hemophilia A
Sanofi 3
Large-scale testing (Phase 3)Looking for participantsNCT06716814
What this trial is testing

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

Who this might be right for
Haemophilia A (Moderate or Severe)
Swedish Orphan Biovitrum 104
Testing effectiveness (Phase 2)Ended earlyNCT06611436
What this trial is testing

BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B

Who this might be right for
Hemophilia BHemophilia B, Moderately Severe or Severe
Be Biopharma 5
Not applicableStudy completedNCT02362581
What this trial is testing

Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A

Who this might be right for
ProphylaxisHemophilia A
Chulalongkorn University 15
Not applicableUnknownNCT02622646
What this trial is testing

Personalized Prophylactic Treatment With Advate® in Severe or Moderate Haemophilia A Patients

Who this might be right for
Hemophilia AFactor VIII
Hospital Universitario La Fe 25
Testing effectiveness (Phase 2)Looking for participantsNCT07226206
What this trial is testing

A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

Who this might be right for
Hemophilia A
Hoffmann-La Roche 5
Not applicableStudy completedNCT02396862
What this trial is testing

Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment

Who this might be right for
Hemophilia A
Bayer 272
Post-approval studies (Phase 4)Study completedNCT01085344
What this trial is testing

Canadian Hemophilia Prophylaxis Study

Who this might be right for
Severe Hemophilia A
The Hospital for Sick Children 56
Post-approval studies (Phase 4)Study completedNCT04286412
What this trial is testing

Nonacog Alfa Prophylaxis And Treatment Of Bleeding Episodes In Previously Treated Patients With Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 25
Large-scale testing (Phase 3)Study completedNCT01174446
What this trial is testing

Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients

Who this might be right for
Hemophilia B
Baxalta now part of Shire 86
Not applicableStudy completedNCT01034904
What this trial is testing

Health Related Quality of Life of Youth and Young Adults With Hemophilia A

Who this might be right for
Hemophilia A
CSL Behring 48
Not applicableStudy completedNCT04165135
What this trial is testing

An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment

Who this might be right for
Severe Hereditary Factor VIII Deficiency Disease Without InhibitorModerate Hereditary Factor VIII Deficiency Disease Without InhibitorHaemophilia A
Hoffmann-La Roche 103
Next Page